Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease
Catherine C. Cohen, Kelvin W. Li, Adina Alazraki, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
Rong Li, Junyan Zou, Wei Ran, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 146
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
Xufen Zeng, Krista A Varady, Xiangdong Wang, et al.
Metabolism (2024) Vol. 161, pp. 156028-156028
Closed Access | Times Cited: 23
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada El‐Shabrawi, Louise A. Baur, et al.
Med (2024) Vol. 5, Iss. 7, pp. 797-815.e2
Closed Access | Times Cited: 18
Fructose drives de novo lipogenesis affecting metabolic health
Bettina Geidl-Flueck, Philipp A. Gerber
Journal of Endocrinology (2023) Vol. 257, Iss. 2
Open Access | Times Cited: 24
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
Tianyu Mao, Yiwen Sun, Xinyi Xu, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 16
LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Shizan Xu, Yajie Wang, Zhengyang Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 25
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S244-S260
Open Access | Times Cited: 25
The Impact and Burden of Dietary Sugars on the Liver
Helaina Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 14
Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics
Camila Farías, Camila Cisternas, Juan Cristóbal Gana, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4829-4829
Open Access | Times Cited: 14
New insights on mesenchymal stem cells therapy from the perspective of the pathogenesis of nonalcoholic fatty liver disease
Yanxuan Wen, Jiaxing Li, Omar Mukama, et al.
Digestive and Liver Disease (2025)
Closed Access
Special correlation between diet and MASLD: positive or negative?
Jia Liu, C. S. Li, Yun Yang, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Nutritional regulation of hepatic de novo lipogenesis in humans
Eloise Cross, David Dearlove, Leanne Hodson
Current Opinion in Clinical Nutrition & Metabolic Care (2023) Vol. 26, Iss. 2, pp. 65-71
Closed Access | Times Cited: 11
Progression to Obesity: Variations in Patterns of Metabolic Fluxes, Fat Accumulation, and Gastrointestinal Responses
Fadia Milhem, Slavko Komarnytsky
Metabolites (2023) Vol. 13, Iss. 9, pp. 1016-1016
Open Access | Times Cited: 11
The change of alanine aminotransferase distributions among US youths, NHANES 1988–2020
Arshpreet Kaur Mallhi, Keagan Kiely, Victoria Roy, et al.
Journal of Pediatric Gastroenterology and Nutrition (2025)
Closed Access
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Marina Takawy, Manal F. Abdelmalek
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access
Perinatal obesity primes the hepatic metabolic stress response in the offspring across life span
Sarah K. Stegmann, Christina Vohlen, Nam Gyu Im, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mannose reduces fructose metabolism and reverses MASH in human liver slices and murine models in vivo
John G. Hong, Joshaya C. Trotman, Yvette Carbajal, et al.
Hepatology Communications (2025) Vol. 9, Iss. 4
Open Access
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
Eric Lawitz, Kelvin W. Li, Edna Nyangau, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 9, pp. 100250-100250
Open Access | Times Cited: 16
Association of sugar intake from different sources with cardiovascular disease incidence in the prospective cohort of UK Biobank participants
Sylva M. Schaefer, Anna Kaiser, Gerrit Eichner, et al.
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Dietary fructose: from uric acid to a metabolic switch in pediatric metabolic dysfunction-associated steatotic liver disease
Maria Felicia Faienza, Eleonora Cognetti, Ilaria Farella, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-16
Open Access | Times Cited: 3
Revisiting the concepts of de novo lipogenesis to understand the conversion of carbohydrates into fats: stop overvaluing and extrapolating the renowned phrase "fat burns in the flame of carbohydrate"
Heitor O. Santos, Nilson Penha‐Silva
Nutrition (2024) Vol. 130, pp. 112617-112617
Closed Access | Times Cited: 3
Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis
Isabel Omaña‐Guzmán, Marisol Rosas‐Díaz, Yoscelina Estrella Martínez-López, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity
Emily Miller, Jung H. Suh, Jean‐Marc Schwarz, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 13
Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders
Xiaokang Jia, Qiliang Chen, Hui‐Wen Wu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top